About EnClear

EnClear Therapies was conceived with the sole purpose of developing novel device-based therapies to treat patients with neurodegenerative disease. The company's first products will aim to halt the progression of ALS and PSP.

​

At EnClear Therapies, leading scientific, and clinical minds in the field of neurodegenerative disease have come together with experts in medical device design to bring new therapies to patients who currently have no other options for treatment.​

EnClear Founders

Scientific Adviser, Co-Founder

Kevin Eggan, Ph.D.

Professor in the Department of Stem Cell and Regenerative Biology, Harvard University